Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life by TI Ionova, NB Bulieva, OYu Vinogradova, TA Gritsenko, LK Kozlova, GB Kuchma, EG Lomaia, ER Machyulaitene, TP Nikitina, NV Novitskaya, AYu Rodionova, EI Usacheva, TV Shneider

Get full text